[go: up one dir, main page]

ZA922930B - Organ specific emulsion - Google Patents

Organ specific emulsion

Info

Publication number
ZA922930B
ZA922930B ZA922930A ZA922930A ZA922930B ZA 922930 B ZA922930 B ZA 922930B ZA 922930 A ZA922930 A ZA 922930A ZA 922930 A ZA922930 A ZA 922930A ZA 922930 B ZA922930 B ZA 922930B
Authority
ZA
South Africa
Prior art keywords
pct
emulsion
cyclopenta
phenanthrene
emulsions
Prior art date
Application number
ZA922930A
Other languages
English (en)
Inventor
Bjoern Norrlind
Arvid Wretlind
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of ZA922930B publication Critical patent/ZA922930B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Colloid Chemistry (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA922930A 1991-04-23 1992-04-23 Organ specific emulsion ZA922930B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101214A SE470086B (sv) 1991-04-23 1991-04-23 Organspecifik emulsion

Publications (1)

Publication Number Publication Date
ZA922930B true ZA922930B (en) 1994-10-07

Family

ID=20382533

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922930A ZA922930B (en) 1991-04-23 1992-04-23 Organ specific emulsion

Country Status (19)

Country Link
US (1) US5445811A (sv)
EP (1) EP0581842B1 (sv)
JP (1) JPH06506932A (sv)
AT (1) ATE181241T1 (sv)
AU (1) AU660974B2 (sv)
CA (1) CA2109094A1 (sv)
DE (1) DE69229441D1 (sv)
DK (1) DK0581842T3 (sv)
ES (1) ES2135405T3 (sv)
FI (1) FI934690L (sv)
GR (1) GR3031053T3 (sv)
HU (1) HU210577B (sv)
IE (1) IE921289A1 (sv)
NO (1) NO307449B1 (sv)
NZ (1) NZ242436A (sv)
PT (1) PT100418B (sv)
SE (1) SE470086B (sv)
WO (1) WO1992018169A1 (sv)
ZA (1) ZA922930B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0605477B2 (en) * 1991-09-17 2007-06-20 GE Healthcare AS Gaseous ultrasound contrast media
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
DE69427185T2 (de) * 1993-01-25 2001-12-06 Sonus Pharmaceutical, Inc. Phase-Stift Kolloide zur Verwendung als Ultraschallkontrastmittel
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
US6423363B1 (en) * 1997-08-22 2002-07-23 Lipton, Division Of Conopco, Inc. Aqueous dispersion
ES2187201T3 (es) * 1998-10-14 2003-05-16 Cognis Deutschland Gmbh Empleo de esteroles y de esterolesteres a nanoescala.
US6274574B1 (en) 1999-02-26 2001-08-14 Kraft Foods, Inc. Use of mesophase-stabilized compositions for delivery of cholesterol-reducing sterols and stanols in food products
EP1499206A1 (en) * 2002-04-10 2005-01-26 Thomas P. Binder Hydrothermically processed compositions containing phytosterols
US7306819B2 (en) * 2002-06-12 2007-12-11 The Coca-Cola Company Beverages containing plant sterols
CA2534426A1 (en) * 2003-08-08 2005-02-17 Barnes-Jewish Hospital Emulsion particles for imaging and therapy and methods of use thereof
CA2545524C (en) * 2003-10-24 2012-06-26 The Coca-Cola Company Process for preparing phytosterol dispersions for application in beverages
CH712511B1 (de) * 2006-09-18 2017-11-30 Forim-X Ag C/O Prof Dr Med Richard Dirnhofer Röntgenkontrastmittel für die postmortale, experimentelle und diagnostische Angiographie.
ES2640456T3 (es) 2006-09-18 2017-11-03 Fumedica Ag Agente de contraste de rayos X para la angiografía post mortem, experimental y diagnóstica
FR3039767B1 (fr) 2015-08-04 2017-09-08 Guerbet Sa Composition destinee a vectoriser un agent anticancereux
US20220151886A1 (en) * 2019-04-01 2022-05-19 Conopco, Inc., D/B/A Unilever Multiple emulsion comprising an oil continuous nanoemulsion and a method for using the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB676738A (en) * 1949-11-16 1952-07-30 Bayer Ag Parenterally administrable x-ray contrast agents
GB721264A (en) * 1952-10-13 1955-01-05 Astra Apotekarnes Kem Fab Improvements relating to contrast preparations for visualising the vascular system by x-ray
US3356575A (en) * 1965-04-13 1967-12-05 Leo Ab Autosterile injectable iodinated oil X-ray contrast medium
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
US4404182A (en) * 1980-01-08 1983-09-13 The United States Of America As Represented By The Department Of Health And Human Services Ethiodized oil emulsion for intravenous hepatography
GB2156345B (en) * 1984-03-30 1987-07-08 Squibb & Sons Inc Alkylamine salts of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
CH672733A5 (sv) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
ES2054706T3 (es) * 1987-06-11 1994-08-16 Kabi Pharmacia Ab Emulsion que contiene yodo.
GB8900376D0 (en) * 1989-01-09 1989-03-08 Nycomed As Iodinated esters
AU642066B2 (en) * 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
DE4111939A1 (de) * 1991-04-12 1992-10-22 Fresenius Ag Parenteral verabreichbare, hitzesterilisierbare o/w-emulsion eines roentgenkontrastmittels
SE9101709L (sv) * 1991-06-03 1992-12-04 Karlshamns Lipidteknik Ab Lipidderivat som diagnostikum eller kontrastmedel
US5318768A (en) * 1992-05-01 1994-06-07 Sterling Winthrop Inc. Polymeric x-ray contrast compositions containing an organic crystalline x-ray contrast agent

Also Published As

Publication number Publication date
ATE181241T1 (de) 1999-07-15
JPH06506932A (ja) 1994-08-04
DE69229441D1 (de) 1999-07-22
WO1992018169A1 (en) 1992-10-29
FI934690A0 (fi) 1993-10-22
NO933807L (no) 1993-10-22
SE9101214L (sv) 1992-10-24
EP0581842B1 (en) 1999-06-16
HU9303005D0 (en) 1994-01-28
SE470086B (sv) 1993-11-08
HU210577B (en) 1995-05-29
EP0581842A1 (en) 1994-02-09
GR3031053T3 (en) 1999-12-31
NZ242436A (en) 1994-03-25
IE921289A1 (en) 1992-11-04
HUT65882A (en) 1994-07-28
NO307449B1 (no) 2000-04-10
US5445811A (en) 1995-08-29
DK0581842T3 (da) 1999-11-22
ES2135405T3 (es) 1999-11-01
AU1680592A (en) 1992-11-17
AU660974B2 (en) 1995-07-13
CA2109094A1 (en) 1992-10-24
PT100418A (pt) 1993-08-31
SE9101214D0 (sv) 1991-04-23
PT100418B (pt) 1999-08-31
FI934690L (fi) 1993-10-22

Similar Documents

Publication Publication Date Title
ZA922930B (en) Organ specific emulsion
US5985177A (en) O/W/O type multiple emulsion and method of preparing the same
Baron et al. Thymic cysts following radiation therapy for Hodgkin disease.
JPH08511013A (ja) 乳化したペトロラタムを含有する皮膚保護組成物
Weingarten et al. Interactions of a non-ionic ABA copolymer surfactant with phospholipid monolayers: possible relevance to emulsion stabilization
Skanse et al. The effect of corticotrophin and cortisone on serum lipids and lipoproteins
EP0715517A4 (en) ESTRENSTEROIDS AS NEUROCHEMICAL INITIATORS OF A CHANGE IN HUMOTHALM FUNCTION IN PEOPLE AND RELATED PHARMACEUTICAL PREPARATIONS AND METHODS
Osborn et al. Thin-section computed tomography in the evaluation of third ventricular colloid cysts
Hendrickx et al. Thymic atrophy and rebound enlargement following chemotherapy for testicular cancer
Rubens et al. Norethisterone acetate in the treatment of advanced breast cancer
JP3414008B2 (ja) 複合粉体及び複合粉体含有化粧料
Edsmyr et al. Clinical experimental randomized study of 2.6-cis-diphenylhexamethylcyclotetrasiloxane and estramustine-17-phosphate in the treatment of prostatic carcinoma
Hill The ratio of lithocholic to deoxycholic acid in faeces: a risk factor in colorectal carcinogenesis
Thurmond et al. Radiologic evaluation of the thymus in juvenile myasthenia gravis
JPH10101520A (ja) 皮膚外用剤
Mamdani et al. High-dose bolus urography: A superior technique in advanced renal failure
JP2004238334A (ja) 皮膚外用剤
Harper et al. DROPERIDOL PREMEDICATION
Burgener et al. Retrograde Hepatography and Indirect Lymphography of the Liver: An Experimental Study in the Dog
Krinsky Low-dose corticosteroid therapy for idiopathic pulmonary fibrosis.
Holder et al. Metrizamide myelography with complex-motion tomography.
IMAI Drug-induced non-neoplastic lesions in the liver, special reference to unusual hepatic lesions
Jacobs Medical Radiographic Technic. Rewritten by William L. Bloom, Jr., John L. Hollenbach and James A. Morgan, 351 pages. Price not quoted. Publishers—Charles C. Thomas, Springfield, Illinois, USA
KIRIBUCHI Computerized tomography of ophthalmic lesions
Wu et al. Hard Phase in Steel Bonded Hard Alloys